34 gauge blunt end needle (World Precision Instruments)
World Precision Instruments is a verified supplier 
World Precision Instruments manufactures this product 
93
Structured Review
World Precision Instruments
34 gauge blunt end needle
34 Gauge Blunt End Needle, supplied by World Precision Instruments, used in various techniques. Bioz Stars score: 93/100, based on 41 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/gauge+blunt+end+needle/Nanofil+Application+Kits-RPE-KIT/pmc12036977__pnas__2425523122__sapp-200-1-4
Average 93 stars, based on 41 article reviews
34 Gauge Blunt End Needle, supplied by World Precision Instruments, used in various techniques. Bioz Stars score: 93/100, based on 41 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/gauge+blunt+end+needle/Nanofil+Application+Kits-RPE-KIT/pmc12036977__pnas__2425523122__sapp-200-1-4
Average 93 stars, based on 41 article reviews
34 gauge blunt end needle - by Bioz Stars,
2026-09
93/100 stars
Images
Related Articles
Microscopy:Article Title: Pharmacologic fibroblast reprogramming into photoreceptors restores vision Article Snippet: .. A Article Title: Genomic Form of Rhodopsin DNA Nanoparticles Rescued Autosomal Dominant Retinitis Pigmentosa in the P23H Knock-in Mouse Model Article Snippet: The eyelids were then cut with scissors and the cornea was carefully punctured with a 27-gauge insulin syringe needle (BD, cat. No. 329412). .. Then a Bioprocessing:Article Title: AAV-mediated base-editing therapy ameliorates the disease phenotypes in a mouse model of retinitis pigmentosa Article Snippet: .. One microliter of the compound containing AAV-N and AAV-C at a virus titer of 10 12 or balanced salt solution (BSS) was slowly and manually injected into the temporal subretinal space through the incision using a Article Title: AAV-mediated base-editing therapy ameliorates the disease phenotypes in a mouse model of retinitis pigmentosa. Article Snippet: .. One microliter of the compound containing AAV-N and AAV-C at a virus titer of 1012 or balanced salt solution (BSS) was slowly and manually injected into the temporal subretinal space through the incision using a Virus:Article Title: AAV-mediated base-editing therapy ameliorates the disease phenotypes in a mouse model of retinitis pigmentosa Article Snippet: .. One microliter of the compound containing AAV-N and AAV-C at a virus titer of 10 12 or balanced salt solution (BSS) was slowly and manually injected into the temporal subretinal space through the incision using a Article Title: AAV-mediated base-editing therapy ameliorates the disease phenotypes in a mouse model of retinitis pigmentosa. Article Snippet: .. One microliter of the compound containing AAV-N and AAV-C at a virus titer of 1012 or balanced salt solution (BSS) was slowly and manually injected into the temporal subretinal space through the incision using a Injection:Article Title: AAV-mediated base-editing therapy ameliorates the disease phenotypes in a mouse model of retinitis pigmentosa Article Snippet: .. One microliter of the compound containing AAV-N and AAV-C at a virus titer of 10 12 or balanced salt solution (BSS) was slowly and manually injected into the temporal subretinal space through the incision using a Article Title: Gene augmentation for autosomal dominant retinitis pigmentosa using rhodopsin genomic loci nanoparticles in the P23H +/- knock-in murine model. Article Snippet: Gene therapy for autosomal dominant retinitis pigmentosa (adRP) is challenged by the dominant inheritance of the mutant genes, which would seemingly require a combination of mutant suppression and wild-type replacement of the appropriate gene.. We explore the possibility that delivery of a nanoparticle (NP)-mediated full-length mouse genomic rhodopsin (gRho) or human genomic rhodopsin (gRHO) locus can overcome the dominant negative effects of the mutant rhodopsin in the clinically relevant P23H-knock-in heterozygous mouse model. Our results demonstrate that mice in both gRho and gRHO NP-treated groups exhibit significant structural and functional recovery of the rod photoreceptors, which lasted for 3 months post-injection, indicating a promising reduction in photoreceptor degeneration.. We performed miRNA transcriptome analysis using next generation sequencing and detected differentially expressed miRNAs as a first step towards identifying miRNAs that could potentially be used as rhodopsin gene expression enhancers or suppressors for sustained photoreceptor rescue. Article Title: AAV-mediated base-editing therapy ameliorates the disease phenotypes in a mouse model of retinitis pigmentosa. Article Snippet: .. One microliter of the compound containing AAV-N and AAV-C at a virus titer of 1012 or balanced salt solution (BSS) was slowly and manually injected into the temporal subretinal space through the incision using a Saline:Article Title: Genomic Form of Rhodopsin DNA Nanoparticles Rescued Autosomal Dominant Retinitis Pigmentosa in the P23H Knock-in Mouse Model Article Snippet: The eyelids were then cut with scissors and the cornea was carefully punctured with a 27-gauge insulin syringe needle (BD, cat. No. 329412). .. Then a |